Posttransplantation physiologie features of the lung and obliterative bronchiolitis

Mayo Clinic Proceedings

Volumn 72, Issue 2, 1997, Pages 170-174

  Scott, John P ^a   Peters, Steve G ^a   Mcüougall, John C ^a   Beck, Kenneth C ^a   Midthun, David E ^a  

^a MAYO CLINIC ROCHESTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN CLASS 2; IMMUNOSUPPRESSIVE AGENT;

AGE; ARTERIOSCLEROSIS; ARTERY INTIMA PROLIFERATION; BRONCHIECTASIS; BRONCHIOLITIS; CLINICAL FEATURE; CONFERENCE PAPER; CYTOMEGALOVIRUS INFECTION; FORCED EXPIRATORY VOLUME; GRAFT REJECTION; HUMAN; LUNG BIOPSY; LUNG BLOOD VESSEL; LUNG DIFFUSION CAPACITY; LUNG LAVAGE; LUNG TRANSPLANTATION; RISK FACTOR;

EID: 0031420159     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/72.2.170     Document Type: Article

References (33)

1. Scott JP, Higenbottam TW, Clelland C, Hutter JA, Stewart S, Otulana BA, et al. The natural history of obliterative bronchiolitis and occlusive vascular disease of patients following heart-lung transplantation. Transplant Proc 1989; 21:2592-2593
2. Starnes VA. Heart-lung transplantation: an overview. CardiolClin 1990; 8:159-168
3. Yousem SA, Burke CM, Billingham ME. Pathologic pulmonary alterations in long-term human heart-lung transplantation. HumPathol 1985; 16:911-923
4. Epier GR, Colby TV. The spectrum of bronchiolitis obliterans. Chest 1983; 83:161-162
5. Epler GR, Colby TV, McLoud TC, Carrington CB, Gaensler EA. Bronchiolitis obliterans organizing pneumonia. N Engl JMed 1985; 312:152-158
6. Becroft DM. Bronchiolitis obliterans, bronchiectasis. and other sequelae of adenovirus type 21 infection in young children. JClinPathol 1971; 24:72-82
7. Scott JP, Higenbottam TW, Clelland CA, Stewart S, Smyth RL, McGoldrick JP, et al. Natural history of chronic rejection in heart-lung transplant recipients. J Heart Transplant 1990; 9:510-515
8. Estenne M, Ketelbant P, Primo G, Yernault JC. Human heart-lung transplantation: physiologic aspects of the denervated lung and post-transplant obliterative bronchiolitis. Am RevRespirDis 1987; 135:976-978
9. Sweatman MC, Millar AB, Strickland B, Turner-Warwick M. Computed tomography in adult obliterative bronchiolitis. ClinRadiol 1990; 41:116-119
10. Rabinowich H, Zeevi A, Paradis IL, Yousem SA, Dauber JH, Kormos R, et al. Proliferative responses of bronchoalveolar lavage lymphocytes from heart-lung transplant patients. Transplantation 1990; 49:115-121
11. Cooper JD, Billingham M, Egan T, Hertz MI, Higenbottam T, Lynch J, et al (International Society for Heart and Lung Transplantation). A working formulation for the standardization of nomenclature and for clinical staging of chronic dysfunction in lung allografts. J Heart Lung Transplant 1993; 12:713-716
12. Scott JP, Higenbottam TW, Sharpies L, Clelland CA, Smyth RL, Stewart S, et al. Risk factors for obliterative bronchiolitis in heart-lung transplant recipients. Transplantation 1991; 51:813-817
13. Kramer MR, Stoehr C, Whang JL, Berry GJ, Sibley R, Marshall SE, et al. The diagnosis of obliterative bronchiolitis after heart-lung and lung transplantation: low yield of transbronchial lung biopsy. J Heart Lung Transplant 1993; 12:675-681
14. Taylor PM, Rose ML, Yacoub MH. Expression of MHC antigens in normal human lungs and transplanted lungs with obliterative bronchiolitis. Transplantation 1989; 48:506510
15. Zenati M, Dowling RD, Yousem SA, Hardesty RL, Griffith BP, Casarotto D. New trends in combined transplantation of the heart and lungs. G Ital Cardiol 1989; 19:913922
16. Keenan RJ, Lega ME, Dummer JS, Paradis IL, Dauber JH, Rabinowich H, et al. Cytomegalovirus sérologie status and postoperative infection correlated with risk of developing chronic rejection after pulmonary transplantation. Transplantation 1991; 51:433-438
17. Sissons JG, Borysiewicz LK. Human cytomegalovirus infection. Thorax 1989; 44:241-246
18. Yousem SA, Paradis IL, Dauber JH, Griffith BP. Efficacy of transbronchial lung biopsy in the diagnosis of bronchiolitis obliterans in heart-lung transplant recipients. Transplantation 1989; 47:893-895
19. Sharpies LD, Scott JP, Dennis C, Higenbottam TW, Stewart S, Wreghitt T, et al. Risk factors for survival following combined heart-lung transplantation: the first 100 patients. Transplantation 1994; 57:218-223
20. Scott JP. Aspects of the Development of Obliterative Bronchiolitis Following Heart-Lung Transplantation. Thesis, University of Otago, Dunedin, New Zealand, 1991
21. Whitehead B, Rees P, Sorensen K, Bull C, Higenbottam TW, Wallwork J, et al. Incidence of obliterative bronchiolitis after heart-lung transplantation in children. J Heart Lung Transplant 1993; 12:903-908
22. Eklund A, Hallgren R, Blaschke E, Engstrom-Laurent A, Persson U, Svane B. Hyaluronate in bronchoalveolar lavage fluid in sarcoidosis and its relationship to alveolar cell populations. Eur J Respir Dis 1987; 71:30-36
23. Bjermer L, Lundgren R, Hallgren R. Hyaluronan and type III procollagen peptide concentrations in bronchoalveolar lavage fluid in idiopathic pulmonary fibrosis. Thorax 1989; 44:126131
24. Scott JP, Holt DW, Wallwork J. The role of neutrophils in the pathogenesis of obliterative bronchiolitis. Transpl Int 1994; 7(Suppl):S402-S403
25. Scott JP, Wallwork J. Prevention of obliterative bronchiolitis in heart-lung transplant recipients by xanthine oxidase inhibition. Transpl Int 1992; 5:246-248
26. Yousem SA, Sonmez-Alpan E. Use of a biotinylated DNA probe specific for the human Y chromosome in the evaluation oftheallograftlung. Chest 1991; 99:275-279
27. Blaschke E, Eklund A, Hernbrand R. Extracellular matrix components in bronchoalveolar lavage fluid in sarcoidosis and their relationship to signs of alveolitis. Am Rev Respir Dis 1990; 141:1020-1025
28. Bjermer L, Engstrom-Laurent A, Thunell M, Hallgren R. The mast cell and signs of pulmonary fibroblast activation in sarcoidosis. Int Arch Allergy Appl Immunol 1987; 82:298301
29. Frebourg T, Delpech B, Bercoff E, Senant J, Bertrand P, Deugnier Y, et al. Serum hyaluronate in liver diseases: study by enzymoimmunological assay. Hepatology 1986; 6:392395
30. Billingham ME. Endomyocardial biopsy detection of acute rejection in cardiac allograft recipients. Heart Vessels Suppl 1986; 1:86-90
31. Kiistala U, Paavonen T, Saarelainen I, Aronen H, AskoSeljavaara S, Kariniemi AL, et al. Epidermis is the origin of high creatine kinase levels in skin blister fluid. Acta Derm Venereol 1989; 69:284-287
32. Novick RJ, Andréassian B, Schäfers HJ, Haverich A, Patterson GA, Kaye MP, et al. Pulmonary retransplantation for obliterative bronchiolitis: intermediate-term results of a North American-European series. J Thorac Cardiovasc Surg 1994; 107:755-763
33. Adams DH, Cochrane AD, Khaghani A, Smith JD, Yacoub MH. Retransplantation in heart-lung recipients with obliterative bronchiolitis. J Thorac Cardiovasc Surg 1994; 107:450459